Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents
Molecules · 2023
DOI: 10.3390/molecules28083355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Han-Xu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Process, Hubei Province Key Laboratory of Occupationl Hazard Identification and Control, School of Medicine, Wuhan Univer…. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Nitric Oxide. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hubei Province of China, College Students' innovative Entrepreneurial Training Plan Program of Hubei province.
Abstract (Originalsprache)
Antiplatelet aggregation agents have demonstrated clinical benefits in the treatment of ischemic stroke. In our study, a series of novel nitric oxide (NO)-donating ligustrazine derivatives were designed and synthesized as antiplatelet aggregation agents. They were evaluated for the inhibitory effect on 5′-diphosphate (ADP)-induced and arachidonic acid (AA)-induced platelet aggregation in vitro. The results showed that compound 15d displayed the best activity in both ADP-induced and AA-induced assays, and compound 14a also showed quite better activity than ligustrazine. The preliminary structure-activity relationships of these novel NO-donating ligustrazine derivatives were discussed. Moreover, these compounds were docked with the thromboxane A2 receptor to study the structure-activity relationships. These results suggested that the novel NO-donating ligustrazine derivatives 14a and 15d deserve further study as potent antiplatelet aggregation agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Pharmaceutical Process, Hubei Province Key Laboratory of Occupationl Hazard Identification and Control, School of Medicine, Wuhan University of Science and Technology, Wuhan 430065, China.
ORCID-Profile: Jian-Hui Tian, Yu Zou
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hubei Province of China
- College Students' innovative Entrepreneurial Training Plan Program of Hubei province
- College Students’ innovative Entrepreneurial Training Plan Program of Hubei province
Zitieren
APA
Li, H. X., Tian, J. H., Li, H. Y., Wan, X., & Zou, Y. (2023). Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents. Molecules. https://doi.org/10.3390/molecules28083355
Vancouver
Li HX, Tian JH, Li HY, Wan X, Zou Y. Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents. Molecules. 2023. doi:10.3390/molecules28083355
BibTeX
@article{Li2023,
author = {Li, Han-Xu and Tian, Jian-Hui and Li, Hua-Yu and Wan, Xin and Zou, Yu},
title = {Synthesis and Evaluation of Novel Nitric Oxide-Donating Ligustrazine Derivatives as Potent Antiplatelet Aggregation Agents},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28083355}
}
EUVIMED